$AMRX Q3 '26 Earnings Results & Recap Amneal increased full year 2026 net revenue guidance to $3.15B$3.25B, adjusted EBITDA to $800M$815M, and adjusted diluted EPS to $1.04$1.08; operating cash flow guidance was updated to $325M$375M.
$AMRX Q3 '26 Earnings Results & Recap Amneal increased full year 2026 net revenue guidance to $3.15B$3.25B, adjusted EBITDA to $800M$815M, and adjusted diluted EPS to $1.04$1.08; operating cash flow guidance was updated to $325M$375M.